Colgate-Palmolive announced in late July its second-quarter results and indicated that North American business remains solid, with market share on the rise in such categories as toothpaste and manual toothbrushes.
While still a relatively small piece of the overall intimacy health offerings, sales of intimacy enhancement devices continue on an upward trajectory, reaching $15.5 million in overall sales on 21.8% growth for the 52 weeks ended June 10 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.
Following regulatory approval by the Food and Drug Administration's Center for Biologics Evaluation and Research, GlaxoSmithKline confirmed it has begun shipping the first lots of its 2012-2013 seasonal influenza vaccines to healthcare providers and Centers for Disease Control and Prevention distribution centers.
As many as 47 million women will be gaining greater control over their health care and access to eight new prevention-related healthcare services without paying more out of their own pocket beginning Aug. 1, Health and Human Services secretary Kathleen Sebelius announced Tuesday.
Beauty brand L'Oréal USA is leveraging Clarabridge, a provider of sentiment and text analytics for customer experience management, to monitor what is being said in real time about its 27 brands across social media outlets, including website reviews, product reviews, blogs, Twitter and Facebook.
Apparently less is more when it comes to mouthwash. According to SymphonyIRI Group data, the mouthwash segment has essentially been flat for the 12 weeks ended June 10, yet there proved to be one shining star in the mix: Listerine Zero.
A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.